Homomeric and heteromeric interactions between the ␣IIb and ␤3 transmembrane domains are involved in the regulation of integrin ␣IIb␤3 function. These domains appear to interact in the inactivated state but separate upon integrin activation. Moreover, homomeric interactions may increase the level of ␣IIb␤3 activity by competing for the heteromeric interaction that specifies the resting state. To test this model, a series of mutants were examined that had been shown previously to either enhance or disrupt the homomeric association of the ␣IIb transmembrane domain. One mutation that enhanced the dimerization of the ␣IIb transmembrane domain indeed induced constitutive ␣IIb␤3 activation. However, a series of mutations that disrupted homodimerization also led to ␣IIb␤3 activation. These results suggest that the homo-and heterodimerization motifs overlap in the ␣IIb transmembrane domain, and that mutations that disrupt the ␣IIb͞␤3 transmembrane domain heterodimer are sufficient to activate the integrin. The data also imply a mechanism for ␣IIb␤3 regulation in which the integrin can be shifted from its inactive to its active state by destabilizing an ␣IIb͞␤3 transmembrane domain heterodimer and by stabilizing the resulting ␣IIb and ␤3 transmembrane domain homodimers.
Homomeric and heteromeric interactions between the ␣IIb and ␤3 transmembrane domains are involved in the regulation of integrin ␣IIb␤3 function. These domains appear to interact in the inactivated state but separate upon integrin activation. Moreover, homomeric interactions may increase the level of ␣IIb␤3 activity by competing for the heteromeric interaction that specifies the resting state. To test this model, a series of mutants were examined that had been shown previously to either enhance or disrupt the homomeric association of the ␣IIb transmembrane domain. One mutation that enhanced the dimerization of the ␣IIb transmembrane domain indeed induced constitutive ␣IIb␤3 activation. However, a series of mutations that disrupted homodimerization also led to ␣IIb␤3 activation. These results suggest that the homo-and heterodimerization motifs overlap in the ␣IIb transmembrane domain, and that mutations that disrupt the ␣IIb͞␤3 transmembrane domain heterodimer are sufficient to activate the integrin. The data also imply a mechanism for ␣IIb␤3 regulation in which the integrin can be shifted from its inactive to its active state by destabilizing an ␣IIb͞␤3 transmembrane domain heterodimer and by stabilizing the resulting ␣IIb and ␤3 transmembrane domain homodimers.
␣IIb␤3 ͉ integrin regulation ͉ transmembrane domains I ntegrins reside on cell surfaces in an equilibrium between inactive and active conformations that can be shifted in either direction by altering the distance between the stalks that anchor integrins in cell membranes (1) . At the cellular level, integrin activation is regulated by cellular agonists, but how this occurs is uncertain. In the case of the platelet integrin ␣IIb␤3, membrane-proximal segments of the ␣IIb and ␤3 cytoplasmic (CYT) domains are thought to directly interact to constrain the integrin in an inactive state (2) . Agonist-stimulated talin binding to the ␤3 CYT domain may relieve this constraint, inducing ␣IIb␤3 activation (3) .
The ␣IIb and ␤3 transmembrane domains are also in proximity when the integrin is inactive and separate upon integrin activation (4) . Moreover, these domains readily undergo homomeric interactions in micelles (5) , and both homomeric and heteromeric interactions have been detected in biological membranes (6, 7) . Thus, in the platelet membrane where the concentration of these domains is high, the ␣IIb and ␤3 helices might be expected to form homooligomers in the activated state, crosslinking individual molecules and stabilizing focal adhesions (8) . Indeed, we tested this possibility previously by placing Asn, a residue known to strengthen homomeric transmembrane (TM) interactions (9, 10) , at successive positions across a 10-residue segment of the ␤3 TM domain and found that mutations along one face of the helix led to constitutive ␣IIb␤3 activation and integrin clustering (11) .
However, there are two distinct mechanisms by which TM domain mutations might activate integrins. Besides increasing the tendency of a highly expressed integrin to form homooligomers, TM domain mutations might disrupt heteromeric interactions and activate the integrin in this manner. Here, we examine mutants that either enhance or disrupt homooligomerization of the ␣IIb TM domain. Using the TOXCAT assay, we found previously that the sequence xxVGxxGGxxxLxx is critical for homooligomerization of the ␣IIb TM helix, and we identified mutations in the sequence that either increased or decreased the homomeric association of the ␣IIb TM helix (7). Thus, mutating either Gly in the strong homooligomerization motif GxxxG (12) to Ala, Leu, Val, or Ile decreased dimerization, whereas replacing the downstream Leu with Ala enhanced dimerization. Here, we have determined how these mutations, as well as Asnscanning mutations of the ␣IIb TM helix, affect the ␣IIb␤3 activation state. Like oligomer-enhancing mutations in the ␤3 TM helix (11), we found that the homodimer-enhancing L980A mutation induced constitutive ␣IIb␤3 activity and clustering. However, we found that mutations that disrupted oligomerization also resulted in a constitutively activated phenotype, suggesting that these residues may be located at the interface between the ␣IIb and ␤3 TM domains. Together, these results suggest a push-pull mechanism for the regulation of the ␣IIb␤3 activity: events that disrupt the heterodimerization of the ␣IIb and ␤3 TM domains push the integrin toward the activated state, whereas events that enhance the homomeric association of these domains pull the equilibrium toward activation.
Materials and Methods
Stable Expression of ␣IIb␤3 Mutants in CHO Cells. Mutated ␣IIb and WT ␤3 cDNAs were subcloned into the plasmids pcDNA3.1(ϩ)-Neo and pcDNA3.1(ϩ)-Zeo, respectively, before cotransfection into CHO cells using FUGENE6 (Roche Diagnostics). Transfected cells were grown in a selection medium containing G418 and Zeocin for 3 wk before being sorted twice by FACS for cells expressing high levels of ␣IIb␤3 (11).
Fibrinogen Binding to CHO Cells Expressing ␣IIb␤3. CHO cells, at a density of 2 ϫ 10 6 cell͞ml, were incubated with the ␤3-specific mAb SSA6 (13) on ice for 30 min. The mAb-labeled cells were then washed and incubated for 30 min at 37°C with phycoerythrin (PE)-conjugated anti-mouse IgG (Molecular Probes) and 200 g͞ml FITC-conjugated fibrinogen. Freshly made 5 mM DTT and͞or 5 mM EDTA were added to the incubations as indicated. After incubation, the cells were washed, fixed with 0.37% formalin in PBS, and examined by two-color FACS analysis, as described (14) .
Immunostaining of ␣IIb␤3 on the CHO Cell Surface. ␣IIb␤3 clustering on the CHO cell surface was detected as described (11) . Briefly, 4 ϫ 10 6 CHO cells were fixed by using 4% paraformaldehyde before being transferred to a polylysine-coated chamber glass Abbreviations: CYT, cytoplasmic; TM, transmembrane; PE, phycoerythrin; FAK, focal adhesion kinase; CAT, chloramphenicol acetyl transferase; GpA, glycophorin A. slide. The slides were then washed with 50 mM Tris⅐HCl, pH 7.4, blocked with 5 mg͞ml BSA in PBS, and incubated sequentially with the anti-␤3 mAb SSA6 and FITC-labeled anti-mouse IgG. Stained cells were mounted in Citifluor antifadant mounting material (University of Kent, Canterbury, U.K.) and examined by using a Nikon Microphot-SA fluorescence microscope. Images were captured by using IPLAB SPECTRUM IMAGE ANALYSIS software for the Macintosh and a Photometrics SenSys KF1400 camera (BioVision Technologies, Exton, PA). For each mutant, 30-40 stained cells were selected randomly and photographed.
Focal Adhesion Kinase (FAK) Phosphorylation. FAK phosphorylation in CHO cells adherent to fibrinogen-coated tissue culture plates or resuspended in centrifuge tubes was studied as described (15) . Briefly, FAK was immunoprecipitated from 125 g of total protein from lysed cells and subjected to SDS͞PAGE in a 3-8% NuPAGE Tris-Acetate gel (Invitrogen). Anti-FAK polyclonal antibody (Upstate Biotechnology) was used for immunoprecipitation and immunoblotting. FAK phosphorylation was detected by using a mouse antiphosphotyrosine mAb (Upstate Biotechnology).
Expression and Purification of Proteins Corresponding to the TM͞CYT
Domains of ␣IIb and ␤3. Proteins corresponding to the TM͞CYT domains of ␣IIb and ␤3 were expressed in Escherichia coli strain BL21 and purified by HPLC as described (5) . Briefly, cDNAs corresponding to the ␣IIb and ␤3 TM͞CYT domains were amplified by PCR by using ␣IIb and ␤3 cDNAs as templates, cloned into the vector pGEX-4T-3 (Amersham Pharmacia-Pharmacia), and expressed as glutatione S-transferase-fusion proteins. Synthesized fusion proteins were isolated by affinity chromatography by using glutathione-Sepharose 4B, the glutatione S-transferase was removed by cleavage with thrombin, and the cleaved samples were purified by preparative reverse-phase HPLC and lyophilized. The lyophilized proteins were then dispersed in dodecylphosphocholine dissolved in methanol and dried under a stream of nitrogen. The dried mixture was dissolved in aqueous buffer, and the protein concentration was determined by absorbance at 280 nm. The extinction coefficients for ␣IIb and ␤3 TM͞CYT proteins were calculated as 16,500 M Ϫ1 ⅐cm Ϫ1 and 13,980 M Ϫ1 ⅐cm Ϫ1 , respectively, based on the method by Pace et al. (16) .
Analytical Ultracentrifugation. Equilibrium sedimentation was performed in a Beckman XL-I analytical ultracentrifuge (Beckman Coulter) at 25°C (5). D 2 O was added to the buffer [10 mM dodecylphosphocholine (DPC)͞20 mM 4-morpholinepropanesulfonic acid͞100 mM KCl͞1 mM MgCl 2 , pH 7.4] to 50.34% to match the density of DPC. The molecular mass and partial specific volume of WT and mutant TM͞CYT proteins were calculated and the data sets analyzed as described (5).
TOXCAT Assay. The TOXCAT assay (17) was performed by using the expression vectors pccKAN, pccgpA-wt, and pccgpA-G83I and the E. coli strain MM39 kindly provided by Donald M. Engelman (Yale University, New Haven, CT). After changing the EcoRV restriction site between the TM region and the malB gene in pccKAN to a BamHI site, the vector was digested with NheIBamHI, and genes encoding the ␣IIb and ␤3 TM helices were ligated into the vector in-frame. Subsequent site-directed mutagenesis was performed by using a QuikChange mutagenesis kit (Stratagene). The resulting plasmids were transformed into E. coli MM39 cells. The optimal length of the ␣IIb TM helix for this assay was determined previously (7) . To identify the optimal length for the ␤3 TM helix, we incrementally deleted residues from its C-terminal end. A helix encompassing residues 693-713 resulted in maximal chloramphenicol acetyl transferase (CAT) synthesis (data not shown) and was used in subsequent experiments.
CAT synthesis was assayed by using a CAT-ELISA kit (Roche Applied Sciences, Indianapolis), as described (7). In each experiment, glycophorin A (GpA)-WT was included for comparison. Results were expressed as a percentage of the CAT induced by GpA-WT in the same experiment. Chimeric protein expression was quantified from immunoblots by using a Personal Densitometer SI (Molecular Dynamics) and was used to compare CAT expression by the various constructs.
Structural Model of an ␣IIb␤3 TM Domain
Heterodimer. An atomic model of an ␣IIb͞␤3 TM heterodimer was constructed by using a Monte Carlo simulated annealing algorithm (7) . Two idealized helices corresponding to ␣IIb residues Ile-966 through Trp-988 and ␤3 residues Ile-693 through Trp-715 were docked by using six orthogonal parameters: three rigid body translations and three rotations. All canonical helical rotamers (18) were considered for residues along an interhelix interface; otherwise, the principal helical rotamer was selected. Side-chain conformations were selected by using dead-end elimination at each step of the process, and the energy of each structure was calculated by using the AMBER potential (19) . At each step, the energies of both disruptive as well as silent mutations were evaluated for a given backbone geometry. The program maximizes the Boltzmann probability associated with the ensemble of silent mutations, while minimizing the Boltzmann probability of the ensemble of disruptive mutations. Energy minima were identified by using a simulated annealing algorithm with an exponential temperature decay (see supporting information, which is published on the PNAS web site).
Results
An Asn Substitution in the ␣IIb TM Domain Activates ␣IIb␤3. Addition of Asn to model TM helices promotes their association in biological membranes (9, 10) . Previously, we demonstrated that substituting Asn for either of two appropriately spaced residues in the TM helix of ␤3 enabled ␣IIb␤3 to constitutively bind fibrinogen and enhanced the tendency of the helix to form homotrimers (11) . As shown in Table 1 , we placed Asn at 10 consecutive positions in the ␣IIb TM helix extending from residues V969 to L978 and coexpressed each mutant with WT ␤3 in CHO cells. We then measured the effect of the mutations on the ability of ␣IIb␤3 to bind fibrinogen constitutively and to form spontaneous ␣IIb␤3 clusters. Despite our previously reported results (11) , the outcome of the current experiments was not predictable, because a single Asn can be a weaker signal for oligomerization than the preexisting strong dimerization GxxxG motif found in the ␣IIb TM domain (20, 21) . Unless these two signals reinforce one another (22) , it is possible that introducing Asn could disrupt the intrinsic tendency of the helix to dimerize.
We found the expression of ␣IIb␤3 containing 6 of the 10 Asn mutants on the CHO cell surface was comparable to that of ␣IIb␤3 containing WT ␣IIb (data not shown). However, the V971N, V973N, G976N, and L977N mutants were consistently expressed at substantially lower levels, suggesting their presence had a deleterious effect on ␣IIb␤3 biosynthesis.
We then used FACS analysis to measure the ability of WT ␣IIb␤3 and the highly expressed ␣IIb mutants to bind soluble fibrinogen, either constitutively or after ␣IIb␤3 activation using DTT. WT ␣IIb␤3, as well as each of the ␣IIb mutants, readily bound fibrinogen after exposure to DTT but only the G972N mutant bound fibrinogen constitutively. As shown in Fig. 1A , ␣IIb␤3 containing the G972N mutation bound Ϸ8-fold more fibrinogen than did WT ␣IIb␤3 in the absence of DTT. Moreover, as illustrated by the histograms in Fig. 1B , Ϸ34% of the G972N cells expressed constitutively activated ␣IIb␤3, compared to only 3% of the WT cells. Nonetheless, both constitutive and DTT-induced fibrinogen binding was inhibited by the divalent cation chelator EDTA, consistent with specific fibrinogen binding to ␣IIb␤3 (11) . Activating ␣IIb␤3 by introducing Asn into the ␤3 TM helix resulted in ␣IIb␤3 clustering (11) . To determine whether replacing G972 in the ␣IIb TM helix with Asn had the same effect, CHO cells expressing WT ␣IIb␤3 or the G972N mutant were fixed, stained sequentially with the ␤3-specific mAb SSA6 and FITC-labeled anti-mouse IgG, and examined by fluorescence microscopy. As shown in Fig. 2A , WT ␣IIb␤3 was present as a homogenous ring at the cell periphery. This ring was not present in cells expressing the G972N mutant; rather, ␣IIb␤3 was distributed in patches on the CHO cell surface, consistent with the presence of ␣IIb␤3 clusters.
␣IIb␤3 clustering is accompanied by the autophosphorylation of FAK on tyrosine residues (23), as well as phosphorylation of FAK by activated Src kinases (24) . To confirm that the fluorescent patches on cells expressing G972N resulted from ␣IIb␤3 clustering, we measured FAK phosphorylation in CHO cells expressing WT ␣IIb␤3 and the G972N and L974N mutants, both when the cells were adherent to fibrinogen and after they were placed in suspension (Fig. 2B) . As expected, FAK was phosphorylated in adherent CHO cells expressing WT ␣IIb␤3 and those expressing either mutant, but little or no phosphorylation remained after cells expressing WT ␣IIb␤3 and the L974N mutant were resuspended (11) . By contrast, FAK phosphorylation was unchanged when the G972N cells were resuspended, implying that the G972N mutation promotes downstream signaling events known to depend on integrin clustering. Taken together, the results shown in Figs. 1 and 2 demonstrate that replacing G972 in the ␣IIb TM helix with Asn shifts ␣IIb␤3 from its inactive to its active conformation and induces the formation of ␣IIb␤3 clusters as well.
Mutations That Disrupt ␣IIb TM Domain Dimerization Increase ␣IIb␤3
Activity. G972 is the first residue of a GxxxG motif that is essential for ␣IIb TM helix oligomerization (7). We used the TOXCAT assay to assess the effect of G972N on the dimerization of the ␣IIb TM helix. TOXCAT measures the dimerization of a chimeric protein containing a TM helix in the E. coli inner membrane via the transcriptional activation of the reporter gene CAT (17) . We found that replacing G972 with Asn resulted in a 55% decrease in CAT expression compared with the WT ␣IIb TM helix, whereas L974N, a mutation that has no effect on ␣IIb␤3 function, resulted in CAT expression that was similar to WT ␣IIb (Fig. 3A) . The disruptive effect of G972N on ␣IIb TM helix dimerization in bacterial membranes was confirmed by equilibrium sedimentation in dodecylphosphocholine micelles: introducing the mutation into a peptide encompassing the ␣IIb TM and CYT domains resulted in an Ϸ3-fold decrease in its tendency to oligomerize (Table 2) . By contrast, mutating G708 to Asn within the ␤3 TM helix (Table 1 ) resulted in an 8-fold increase in the tendency of a ␤3 TM͞CYT peptide to oligomerize. These data imply that the ␣IIb␤3 activation and clustering induced by G972N in the ␣IIb TM domain is not a result of an enhancement in its ability to form homooligomers.
To confirm further this conclusion in eukaryotic cell membranes, we examined a series of mutations with impaired abilities to form ␣IIb homodimers. Mutating either Gly in the ␣IIb GxxxG motif to Ala, Leu, Val, or Ile impaired dimerization of the ␣IIb helix in TOXCAT (7) . Therefore, we introduced the disruptive ␣IIb mutations G972L, G976A, and G976L, as well as the neutral mutation L983A, into WT ␣IIb␤3 and measured their effect on ␣IIb␤3 activity in CHO cells. As shown in Figs. 3B and 4, each of the disruptive mutations induced constitutive fibrinogen binding to ␣IIb␤3, as well as ␣IIb␤3 clustering, whereas the neutral L983A mutation did neither. Thus, these experiments confirm that disruptive mutations in the ␣IIb GxxxG motif not only impair homodimerization of the ␣IIb TM helix in vivo but also shift ␣IIb␤3 to its active conformation.
L980A, a Mutation in the ␣IIb TM Domain Mutation That Enhances Its
Dimerization, Induces Constitutive ␣IIb␤3 Activation. Unlike G972N, mutating L980 to Ala results in a 2.5-fold increase in CAT expression over the WT ␣IIb TM domain in TOXCAT, and its enhancing effect on ␣IIb TM helix oligomerization is apparent using SDS͞PAGE and analytical ultracentrifugation (7) . To determine whether the enhancing effect of L980A affects ␣IIb␤3 function, we introduced the mutation into full-length ␣IIb and compared fibrinogen binding to WT ␣IIb␤3 and the ␣IIb mutant. As shown in Fig. 5A , ␣IIb␤3 containing L980A constitutively binds Ϸ6.5-fold more fibrinogen than WT ␣IIb␤3 and Ϸ34% of the cells containing the mutant express constitutively activated ␣IIb␤3. Moreover, like other activating TM helix mutations, L980A caused ␣IIb␤3 patching on the CHO cell surface, consistent with ␣IIb␤3 clustering (Fig. 5B) .
Structural Model of an ␣IIb͞␤3 TM Domain Heterodimer. Although isolated ␣IIb TM domains undergo homomeric association in micelles (5) and lipid bilayers (6), the ability of mutations that disrupt this association to activate ␣IIb␤3 implies that other interactions involving this domain must be involved in this process. Recently, Schneider and Engelman (6), using the GAL-LEX assay, reported that the ␣IIb and ␤3 TM domains undergo both homomeric and heteromeric associations in bacterial membranes, and Luo et al. (25) used disulfide bond-scanning of the ␣IIb and ␤3 TM domains to identify a heterodimerization Fig. 4 . Fluorescence microscopy of CHO cells expressing WT ␣IIb␤3 and the ␣IIb mutants G972L, G976L, G976A, and L983A. Cells were fixed with paraformaldehyde, incubated sequentially with the mAb SSA6 and FITC-labeled anti-mouse IgG, and examined by fluorescence microscopy. Representative images are shown. *(P͞L)50 corresponds to the protein͞detergent ratio at which the fraction of monomeric protein is 50% and is a measure of its tendency to oligomerize.
interface in the inactive integrin. Thus, these observations suggest that the ␣IIb GxxxG motif may participate in heteromeric interactions with the ␤3 subunit, and this interaction helps to maintain ␣IIb␤3 in an inactive state. To explore this possibility, we constructed an atomic model for an ␣IIb͞␤3 TM heterodimer. Structural fitness of the model was evaluated by using a recently devised scoring protocol that automatically incorporates mutagenesis data into the energy function. Initial docking attempts identified local minima with right-and lefthanded crossing angles. The left-handed structures failed to converge to a single geometry, and none of the glycines in the ␣IIb GxxxG motif formed C␣-H hydrogen bonds with ␤3 carbonyls or side chains. Although these structures represent possible geometries for the heterodimeric interface (26, 27) , we place more confidence in the right-handed structures, which show lower energies and more extensive interactions. The structures with the lowest energy had a GpA-like crossing angle of 15-40° (Figs. 6 A and B) . In the structure with a 40°angle, ␣IIb Gly-972 and Gly-976 are involved in intimate contact with the ␤3 TM domain, explaining the sensitivity of the heterodimeric interface to mutation. Furthermore, although this model was made before the availability of disulfide crosslinking data from Luo et al. (25) , there is good agreement over the faces of both the ␤3 and ␣IIb helices that contact in the complex.
Discussion
Integrin TM domains undergo homomeric and heteromeric interactions (6), but it has only recently become clear that these interactions may play an important role in regulating integrin function. Previously, we scanned the ␤3 TM domain with Asn residues and found that an appropriately placed Asn not only enhanced its homomeric association but also induced constitutive ␣IIb␤3 activity (11) . Here, we studied the effect of ␣IIb TM domain mutations on aIIb␤3 function using Asn scanning mutagenesis, as well as mutations shown previously to disrupt or enhance the homomeric association of the ␣IIb TM domain (7). As was the case for ␤3, we found that an enhancing mutation, L980A, induced constitutive ␣IIb␤3 activity. This finding is consistent with the overall conclusions of our earlier studies. However, because L980A is close to the heterodimeric TM interface predicted in the current work, we cannot rule out the possibility that the disruption of this heterodimeric association could contribute to the ability of L980A to activate ␣IIb␤3. We also found that a series of mutations that disrupt the GxxxG motif mediating homodimerization of the ␣IIb TM domain activate ␣IIb␤3 (7). The most likely explanation for this finding is that the GxxxG motif is involved not only in homomeric ␣IIb interactions but in heteromeric ␣IIb͞␤3 interactions as well. This conclusion is consistent with the findings of Schneider and Engelman (6) , who used the GALLEX assay to demonstrate heteromeric, as well as homomeric, association of various integrin TM domains in bacterial membranes. Moreover, they found that mutations of the SxxxG motif in ␣4 and the GxxxG motif in ␤7 impaired the formation of ␣4 and ␤7 homodimers, as well as ␣4␤7 heterodimers, suggesting that such motifs are important for both types of interaction.
Using a cysteine-scanning approach to capture a ␣IIb͞␤3 TM domain heterodimer and localize a heterodimerization interface, Luo et al. (25) observed the formation of disulfide bonds between cysteine substitutions in the ␣IIb and ␤3 TM domains with a helical periodicity and involving residues at positions 966, 968, 969, 971, and 972 in ␣IIb and 693, 694, 696, 697, 698, and 700 in ␤3, implying there is a unique orientation between the two helices. Our own computational protocol, which explicitly considers data from the ␣IIb͞␤3 TM mutagenesis experiments, predicted a helix-helix interface that is in good agreement with these mutagenesis data. Although the data are not yet sufficient to provide a single model, some features are clearly predicted and are different from previous models. Structures with a GpA-like crossing angle of 15-40°had the lowest overall energy; other structures consistent with the data had the same sides of the helices in the interface, but the helical axes crossed at different angles. Consistent with results reported by Luo et al. (25) , the model places ␣IIb G972 and ␤3 L697 in the heterodimer interface, but unlike previous models, it places the ␤3 SxxxA motif on the opposite face of the helix. It is also noteworthy that a GpA-like crossing angle predicts ␣IIb and ␤3 TM domains of 26-27 residues, placing the first several residues of what has been considered to be their CYT domains (28) in the membrane bilayer, a prediction consistent with the borders of integrin TM domains determined by glycosylation mapping (29, 30) .
Models of ␣IIb͞␤3 TM helix heterodimers have been reported previously. Gottschalk and coworkers (26) docked 16 integrin heterodimer pairs, including ␣IIb␤3, by using a simulated annealing algorithm and five variable parameters. Based on sequence alignment and prior analysis of the GxxxG motif, they identified a GpA-like structure containing the ␣IIb GxxxG and ␤3 SxxxA motifs, as well as a second conformation in which the ␤-subunit is rotated by Ϸ100°. Subsequent annealing and molecular dynamics simulations supported a model in which the ␣IIb and ␤3 TM domains interact weakly in a right-handed coiled-coil when the integrin is in the low-affinity conformation (27) . Adair and Yeager (31) also proposed that the ␣IIb and ␤3 TM domains associate in an ␣-helical coiled coil. The ␣IIb͞␤3 sequence was aligned by using the putative Arg-Asp clasp (2) and mapped onto a left-handed leucine zipper or a right-handed coiled coil.
Taken together with previous work, our data suggest a pushpull mechanism for integrin activation. Any process that destabilizes the association of the ␣ and ␤ TM domains would be expected to allow dissociation of the TM domains with concomitant activation of the integrin. Thus, mutations that disrupt the heteromeric TM helix interface activate ␣IIb␤3. Furthermore, the CYT domains are also believed to interact with one another, and they may play important roles in integrin activation. Mutations or modifications that disrupt the interaction of the ␣ with the ␤ CYT domains should weaken the interactions of the proximal TM domains, thereby leading to activation.
Conversely, any intermolecular interaction that either requires the separation of the ␣ and ␤ TM͞CYT domains or is more favorable when they dissociate should pull the equilibrium toward the activated state. Thus, interaction of the cytoplasmic domains with talin or other cytoplasmic proteins would lead to activation if complex formation weakened the interactions between the ␣ and ␤ TM͞CYT domains. Previously, we hypothesized that homooligomerization of the TM domains can also drive the equilibrium toward the activated state. Our results with mutations to the TM domain of ␤3 and the homooligomerization-promoting mutation L980A are consistent with this hypothesis. Nonetheless, our results with mutations that disrupt the homomeric interaction of the ␣IIb TM domain, but activate ␣IIb␤3, indicate that homooligomerization is not essential for activation. Instead, homooligomerization appears to be one of several mechanisms to pull the equilibrium toward the activated state.
